Victory Capital Management
RVMD icon

Victory Capital Management’s Revolution Medicines RVMD Stock Holding History

Victory Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.2M Buy
230,909
+88,331
+62% +$12.9M 0.02% 639
2026
Q1 		$13.9M Buy
142,578
+3,266
+2% +$330K 0.01% 996
2025
Q4 		$11.1M Sell
139,312
-112,498
-45% -$7.38M 0.01% 1027
2025
Q3 		$11.8M Sell
251,810
-115,283
-31% -$4.51M 0.01% 1051
2025
Q2 		$13.5M Buy
367,093
+29,212
+9% +$1.12M 0.01% 1015
2025
Q1 		$11.9M Sell
337,881
-92,581
-22% -$3.76M 0.01% 986
2024
Q4 		$18.8M Sell
430,462
-7,288
-2% -$368K 0.02% 864
2024
Q3 		$19.9M Sell
437,750
-104,851
-19% -$4.57M 0.02% 849
2024
Q2 		$21.1M Sell
542,601
-57,980
-10% -$2.17M 0.02% 796
2024
Q1 		$19.4M Buy
600,581
+42,212
+8% +$1.25M 0.02% 831
2023
Q4 		$16M Buy
558,369
+216,010
+63% +$5.19M 0.02% 862
2023
Q3 		$9.48M Buy
342,359
+272,848
+393% +$8.09M 0.01% 1037
2023
Q2 		$1.86M Buy
69,511
+24,101
+53% +$591K ﹤0.01% 1420
2023
Q1 		$984K Sell
45,410
-2,860
-6% -$70.4K ﹤0.01% 1701
2022
Q4 		$1.15M Buy
48,270
+23,070
+92% +$491K ﹤0.01% 1656
2022
Q3 		$497K Buy
+25,200
New +$554K ﹤0.01% 2058
2021
Q4 		– Sell
-7,396
Closed -$203K – 2837
2021
Q3 		$203K Sell
7,396
-357
-5% -$10.4K ﹤0.01% 2523
2021
Q2 		$246K Sell
7,753
-748,111
-99% -$26.1M ﹤0.01% 2481
2021
Q1 		$34.7M Buy
755,864
+707,459
+1,462% +$31.7M 0.04% 700
2020
Q4 		$1.92M Sell
48,405
-7,578
-14% -$300K ﹤0.01% 1532
2020
Q3 		$1.95M Buy
55,983
+36,593
+189% +$1.01M ﹤0.01% 1452
2020
Q2 		$612K Sell
19,390
-44,219
-70% -$1.39M ﹤0.01% 1923
2020
Q1 		$1.39M Buy
+63,609
New +$1.76M ﹤0.01% 1453

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Victory Capital Management's RVMD Position: Q2 2026 in Review

Victory Capital Management increased its Revolution Medicines (RVMD) stake by 62% in Q2 2026, buying an estimated $12.9M and bringing the position to 230,909 shares worth $43.2M. The position accounts for 0.02% of the portfolio, ranked #639.

Victory Capital Management first reported a position in RVMD in Q1 2020 and has held it in 23 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Victory Capital Management held 230,909 shares of Revolution Medicines worth $43.2M as of Q2 2026.
  • Victory Capital Management bought 88,331 Revolution Medicines shares in Q2 2026, an estimated $12.9M.
  • Revolution Medicines made up 0.02% of Victory Capital Management's portfolio in Q2 2026, its #639 holding.
  • Victory Capital Management first reported a position in Revolution Medicines in Q1 2020 and has held it in 23 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.